Physorg -- According to new research by Rockefeller University scientists and their colleagues at Columbia University, which followed a large population of elderly people for more than four years, blood levels of a protein called Amyloid-ß 42 (Aß42) may allow doctors to detect an individual’s predisposition to developing the disease. The findings, published online in the Proceedings of the National Academy of Sciences, have the potential to change the way that the disease is treated and, one day, perhaps even prevent it from taking hold.
